MediciNova Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for MediciNova, Inc. (MNOV) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2018
Operating Activities
Net Income-11.05-8.57-14.07-10.13-13.85-14.68
Depreciation & Amortization0.020.020.020.030.020.03
Stock Based Compensation1.190.710.641.723.180.00
Change in Working Capital-0.980.110.33-1.21-0.38-0.78
Change in Accounts Payable-0.310.020.33-1.030.000.00
Change in Other Working Capital-0.67-0.150.010.22-0.370.00
Other Operating Activities0.17-0.15-0.150.220.000.00
Net Cash from Operating Activities-10.64-7.43-12.91-9.38-10.83-9.11
Investing Activities
Capital Expenditures0.00-0.02-0.01-0.03-0.04-0.01
Acquisitions0.000.000.000.000.000.64
Purchases of Investments0.0039.93-40.000.000.000.00
Sales/Maturities of Investments0.0039.9319.880.000.000.00
Other Investing Activities0.000.000.000.000.000.00
Net Cash from Investing Activities0.0039.91-40.01-0.03-0.040.63
Financing Activities
Common Stock Issued0.000.000.0120.897.3142.76
Other Financing Activities0.000.000.00-0.12-0.200.00
Net Cash from Financing Activities0.000.000.0120.787.1142.81
Summary
Effect of Forex Changes on Cash0.000.02-0.020.030.000.00
Net Change in Cash-10.6432.48-52.9311.37-3.7634.32
Cash at Beginning of Period51.0018.5171.4360.040.0027.99
Cash at End of Period40.3651.0018.5171.430.0062.31
Free Cash Flow-10.64-7.45-12.92-9.41-10.86-9.12
Supplemental Disclosures
Income Taxes Paid0.010.000.000.000.000.01